From DNA to RNA to disease and back: the 'central dogma' of regulatory disease variation.
Much of the focus of human disease genetics is directed towards identifying nucleotide variants that contribute to disease phenotypes. This is a complex problem, often involving contributions from multiple loci and their interactions, as well as effects due to environmental factors. Although some diseases with a genetic basis are caused by nucleotide changes that alter an amino acid sequence, in other cases, disease risk is associated with altered gene regulation. This paper focuses on how studies of gene expression variation might complement disease studies and provide crucial links between genotype and phenotype.
Stranger
Barbara E
BE
The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK. bes@sanger.ac.uk
Dermitzakis
Emmanouil T
ET
D004247:DNA / Q000235:genetics*; D004194:Disease; D005786:Gene Expression Regulation / Q000235:genetics*; D014644:Genetic Variation / Q000235:genetics*; D015894:Genome, Human / Q000235:genetics; D006801:Humans; D012313:RNA / Q000235:genetics*
D012313:RNA; D004247:DNA